Back to Research Hub
Incyte Corporation
INCY
$103.23+2.59 (+2.57%)
Incyte Corporation, a biopharmaceutical company, focuses on the discovery, development, and commercialization of proprietary therapeutics in the United States and internationally.
StreetsValue research for Incyte Corporation (INCY)
Members get the full report for Incyte Corporation: a fair value estimate and valuation analysis, economic moat rating, growth and profitability factor grades, a bull and bear investment thesis, analyst price targets, insider and congressional trading activity, and which super investors own the stock.